Siemens Healthcare is offering a new educational Webinar titled, “Relevancy of PSA Testing.” Excluding skin cancer, prostate cancer is the most commonly diagnosed cancer among men in the US and the second most common cause of cancer death among men. It is estimated that about one in six men in the US will be diagnosed with prostate cancer during their lifetime. The 5-year survival is 100% when cancer is detected in stage I; therefore, early diagnosis and treatment is critical.
This Webinar will review the current role of PSA biomarkers, strategies for increasing specificity of PSA testing, and offer expert advice for optimizing risk assessment protocols.
The Webinar takes place on Tuesday, July 12, and will be hosted by Judd W. Moul, MD, FACS, professor and chief, division of urology, department of surgery, Duke University Medical Center, Durham, NC. This program has been designated for 1.0 PACE continuing education credit.
To register, click here.
